Vinnova grants one-carbon therapeutics money

by admin
mars 29, 2022

One-carbon therapeutics AB is granted 3,000,000 SEK from Sweden’s innovation agency Vinnova under the Medtech4Health and SweLife programs for further development of the MTHFD2 program.

Rekommenderade artiklar

Detailed mode of action of the MTHFD1/2 inhibitor TH9619 now published in Nature Metabolism

The One-carbon Therapeutics team is proud and excited to share

We are presenting our novel MTHFD1/2 inhibitor at the DDR inhibitor summit

We are presenting our data at the DDR inhibitor summit,

One-carbon Therapeutics receives US patent

We are happy to announce that on the 22nd of

Menu bar